A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription

The Journal of Biological Chemistry
Michelle Matter, E Ruoslahti

Abstract

Integrin-mediated cell adhesion is necessary for the survival of many cell types, and loss of adhesion causes apoptosis. We have previously shown that the alpha5beta1 integrin supports cell survival on fibronectin and increases Bcl-2 protein expression. Here we show that bcl-2 transcription is elevated in cells that attach to fibronectin through alpha(v)beta1 or to vitronectin through alpha(v)beta3 but is not elevated in cells attaching through the alpha(v)beta1 integrin. Bcl-2 protein expression and protection from apoptosis under serum-free conditions correlated with bcl-2 transcription. This integrin-mediated regulation of bcl-2 is Shc- and FAK-dependent, and activation of Ras by FAK is required. Furthermore, Ras mediates this up-regulation of bcl-2 by activating the phosphatidylinositol 3-kinase-AKT pathway. Mitogen-activated protein kinase did not appear to be necessary for the activation of bcl-2 transcription. Therefore, our work characterizes the pathway that mediates the effect of integrins on bcl-2 transcription and cell survival.

References

Nov 6, 1986·Journal of Immunological Methods·H TadaK Tsukamoto
Jun 20, 1995·Proceedings of the National Academy of Sciences of the United States of America·Z ZhangE Ruoslahti
Mar 1, 1994·Cancer Metastasis Reviews·R Khosravi-Far, C J Der
Oct 28, 1993·Nature·S E Egan, R A Weinberg
Aug 1, 1996·The Journal of Cell Biology·S M FrischP Y Chan-Hui
Nov 15, 1996·Cell·T F Gajewski, C B Thompson
Dec 1, 1996·The Journal of Cell Biology·J E HungerfordC A Otey
Sep 25, 1997·Trends in Biochemical Sciences·B M Marte, J Downward
Oct 23, 1997·Current Opinion in Cell Biology·S M Frisch, E Ruoslahti
Aug 1, 1997·The International Journal of Biochemistry & Cell Biology·J L Guan
Aug 8, 1998·Trends in Cell Biology·D D Schlaepfer, T Hunter
Dec 16, 1998·Nature·J Downward
Jun 4, 1999·Progress in Biophysics and Molecular Biology·D D SchlaepferD J Sieg
Aug 10, 1999·Experimental Cell Research·D L BrassardL Armstrong
Aug 14, 1999·Science·F G Giancotti, E Ruoslahti
Sep 15, 1999·Nature·J A Romashkova, S S Makarov
Mar 29, 2000·The Journal of Biological Chemistry·A PapapetropoulosW C Sessa
Feb 7, 2001·The Journal of Biological Chemistry·S PugazhenthiJ E Reusch

❮ Previous
Next ❯

Citations

Sep 26, 2013·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Xiaohong WuXingxing Gu
May 3, 2011·Seminars in Immunopathology·Ian B Copland, Jacques Galipeau
Nov 1, 2005·Cancer Metastasis Reviews·Peter J Reddig, Rudy L Juliano
Sep 1, 2012·Clinical & Experimental Metastasis·Cheng ShaoqiangZhang Qingyuan
Feb 13, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·G Chometon, V Jendrossek
Apr 28, 2004·Current Opinion in Genetics & Development·Nastaran Zahir, Valerie M Weaver
Oct 25, 2003·Toxicology and Applied Pharmacology·Antonio ScibelliRossella Della Morte
Sep 7, 2001·Current Opinion in Cell Biology·S M Frisch, R A Screaton
Jul 16, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Henk J BroxtermanKlaas Hoekman
May 4, 2004·Nature Cell Biology·Dwayne G Stupack, David A Cheresh
Dec 24, 2009·Nature Reviews. Cancer·Jay S Desgrosellier, David A Cheresh
Mar 15, 2003·Nature Reviews. Cancer·Erkki Ruoslahti
Mar 15, 2003·Nature Reviews. Cancer·John D Hood, David A Cheresh
Jan 30, 2013·Nature Reviews. Endocrinology·Pierre J Marie
Oct 22, 2008·Oncogene·D A Cheresh, D G Stupack
Jun 4, 2005·Cell Death and Differentiation·D G Stupack
May 25, 2002·Cellular Microbiology·Ozlem YilmazRichard J Lamont
Mar 9, 2011·The Journal of Biological Chemistry·Genevieve S GriffithsMichelle L Matter
Feb 3, 2005·The Journal of Experimental Medicine·Stefan KraftJean-Pierre Kinet
Aug 19, 2007·Molecular Biology of the Cell·Frederique M D TholozanRoy A Quinlan
Dec 27, 2011·Cardiovascular Research·Berit I Rosc-SchlüterGabriela M Kuster
Mar 5, 2005·Anti-cancer Drugs·Kazushige KawaiHirokazu Nagawa
Oct 23, 2003·Annual Review of Cell and Developmental Biology·Filippo G Giancotti, Guido Tarone
Sep 24, 2011·Journal of Oncology·Stephan Niland, Johannes A Eble
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yanhua WuLong Yu
Dec 23, 2008·American Journal of Respiratory Cell and Molecular Biology·Tsung-Ming YangV Courtney Broaddus
Jun 16, 2009·American Journal of Respiratory Cell and Molecular Biology·Charles A Powell
Apr 17, 2002·The Journal of Clinical Investigation·Cord BrakebuschReinhard Fässler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis